Om

RAMM Pharma Corp. is a pharmaceutical and medical products company focused on cannabinoid pharmacology and the formulation of cannabis-based pharmaceuticals and related products. The company develops and commercializes a portfolio that includes pharmaceuticals, cosmetics, nutraceuticals, medical devices, and consumables, serving both clinical and consumer-oriented markets. Its product offering includes branded items such as Epifractan and CannabiPiel, reflecting its emphasis on botanical and cannabis-derived formulations. RAMM Pharma Corp. also operates in medical services and product resale activities, with business presence in Uruguay, Poland, and other markets through its subsidiaries. Based in Toronto, Canada, the company participates in the broader life sciences sector by combining product development, manufacturing, and distribution capabilities across pharmaceutical, cosmetic, and wellness categories.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I RAMM PHARMA MED ENDAVU: Køb Ramm Pharma ($RAMM) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Ramm Pharma, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.